CLEVELAND -- ZipGen, Inc. announces the availability for sale of gene amplification primers that are used in the rapid detection of severe acute respiratory syndrome (SARS).
Gene amplification primers provide a fast and reliable method for health agencies, hospitals, and laboratories to detect the presence of the SARS coronavirus in patients. The primers are used with a highly sensitive technology known as polymerase chain reaction (PCR), which rapidly detects the SARS virus from patient samples. The primers can be used for samples from sputum, blood, urine, and fecal matter. With conventional serology being too slow, the SARS epidemic marks the first time in the history of infectious diseases where genetic diagnostics based upon gene amplification has been proven to be the fastest means of detecting the presence of the SARS virus.
ZipGen, Inc. is part of the expanding list of biotechnology-based firms to address the needs of the global medical community in the rapid detection of this newly emergent pathogen. As the world health community copes with this recent deadly disease, new, reliable, and rapid technologies such as these primers will allow for better detection and control of this crisis.
ZipGen, Inc.'s nand existing products include specialty primers for the SARS virus, Mycobacterium tuberculosis, non-tuberculous mycobacterial diseases, foodborne pathogens and custom primers. According to the World Health Organization (WHO) ruberculosis is the single biggest killer of people living with HIV/AIDS (PLWH). The ZipLys Buffer provides a format for cell lysis for nucleic acid extraction from a broad spectrum of bacterial cell types. The ZipLys Myco and ZipLys Bacto Systems are integrated formats that enable isolation, cultivation and nucleic acid extraction from Mycobacterium tuberculosis, atypical Mycobacterium, Nocardia, E. coli and other bacterial cells.
Source: ZipGen, Inc.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Spring Into Safety: How Seasonal Deep Cleaning Strengthens Hospital Infection Control
June 13th 2025Rooted in ancient rituals of renewal, spring-cleaning has evolved from cultural tradition to a vital infection prevention strategy in modern hospitals—one that blends seasonal deep cleaning with advanced disinfection to reduce pathogens, improve air quality, and protect patients.